Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02URX
|
|||
| Former ID |
DIB005298
|
|||
| Drug Name |
KamRAB
|
|||
| Indication | leukaemia [ICD-11: 2A60-2B33; ICD-9: 208.9] | Phase 2/3 | [1] | |
| Company |
Kamada; kedrion biopharma
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02040090) Phase II/III Study of the Safety and Effectiveness of HRIG With Co-administration of Active Rabies Vaccine in Healthy Subjects. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.